HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

poly(3- hydroxybutyrate- co- 3- hydroxyoctanoate)

structure in first source

Also Known As:

PHBO polymer

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Macromolecular Substances: 97
- Polymers: 13051
  - Polyesters: 921
    - Polyhydroxyalkanoates: 56
      - Polyhydroxybutyrates
        poly(3-hydroxybutyrate-co-3-hydroxyoctanoate): 2
  - Biopolymers: 773
    - Polyhydroxyalkanoates: 56
      - Polyhydroxybutyrates
        poly(3-hydroxybutyrate-co-3-hydroxyoctanoate): 2
Lipids: 114793
- Polyhydroxyalkanoates: 56
  - Polyhydroxybutyrates
    - poly(3-hydroxybutyrate-co-3-hydroxyoctanoate): 2

Experts

1.	Zhang, Chan: 2 articles (06/2016 - 01/2016)
2.	Zhao, Liangqi: 2 articles (06/2016 - 01/2016)
3.	Zhang, Zhuo: 1 article (06/2016)
4.	Dong, Yuefeng: 1 article (01/2016)
5.	Wu, Yifan: 1 article (01/2016)
6.	Xu, Hongying: 1 article (01/2016)

Related Diseases

1.	Neoplasms (Cancer) 01/01/2016 - "Doxorubicin (DOX)-loaded folate-targeted poly(3-hydroxybutyrate-co-3-hydroxyoctanoate) [P(HB-HO)] nanoparticles [DOX/FA-PEG-P(HB-HO) NPs] were prepared by the W1/O/W2 solvent extraction/evaporation method for applications in cancer treatment. "
2.	Uterine Cervical Neoplasms (Cancer of the Cervix) 06/01/2016 - "Doxorubicin (DOX)-loaded folate-targeted poly(3-hydroxybutyrate-co-3-hydroxyoctanoate) [P(HB-HO)] nanoparticles [DOX/FA-PEG-P(HB-HO) NPs] have potential application in clinical treatments for cervical cancer due to specific affinity of folate and folate receptor in HeLa cells. "

Related Drugs and Biologics

1.	Folic Acid (Vitamin M)
2.	Doxorubicin (Adriamycin)
3.	Solvents